This progressively increased the adoption of K-DOQI guidelines and, also thanks to specific incentives for UK general physicians to detect CKD, led to an impressive improvement in the detection and care of CKD, in other words, better control of hypertension and increased use of angiotensin-converting enzyme and angiotensin receptor blockers [80]. This evidence concerns the gene ACE and chronic kidney disease.